American academic medical center Mayo Clinic plans to trial generative AI technology on Google Cloud. The nonprofit first announced a 10-year strategic partnership with Google back in 2019. Mayo ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, ...

Google on Thursday announced the second cohort to take part in its AI Academy: American Infrastructure, which seeks to ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper ...

NEW YORK & LAS VEGAS, April 09, 2025--UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models.

After years of development, Murdoch says human clinical trials for Isomorphic’s AI-designed drugs are finally within reach. ... Why Google AI Overviews are facing EU antitrust heat from publishers.

A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.